1.Stevens-Johnson Syndrome and Hypothermia Associated with Anti-tuberculosis Medication in a Patient with Heart Failure.
Sang-Ok JUNG ; Min-Ji CHO ; Dong-Il PARK ; Sun-Young KIM ; Ju-Ock KIM ; Sung-Soo JUNG ; Hee-Sun PARK ; Jeong-Eun LEE ; Jae-Young MOON ; Chae-Uk CHUNG
Chinese Medical Journal 2015;128(20):2837-2838
2.Analysis of Renal Artery Stenosis in Patients with Heart Failure: A RASHEF Study.
Bin ZHENG ; Qin MA ; Li-Hong ZHENG ; Qiang YONG ; Yi-Hua HE ; Jing-Hua LIU
Chinese Medical Journal 2015;128(20):2777-2782
BACKGROUNDPrevious data are controversial about the association of renal artery stenosis (RAS) with clinical outcome in patients with heart failure. Definition of RAS in previous studies might not be appropriate. By definition of RAS with renal duplex sonography, we investigated the association of RAS with clinical outcome in patients with heart failure.
METHODSIn this retrospective study, we identified 164 patients with heart failure (New York Heart Association classification ≥II; left ventricular ejection fraction <50%) who had received renal duplex sonography during hospital stay. RAS was defined as renal-aortic ratio ≥3.5 or a peak systolic velocity ≥200 cm/s (or both), or occlusion of the renal artery. Categorical data of patients were compared using the Chi-square test or Fisher's exact test. Cox proportional hazards regression modeling technique was used to investigate the prognostic significance of possible predictors.
RESULTSFinally, 143 patients were enrolled. Median follow-up time was 32 months (1-53 months). Twenty-two patients were diagnosed as RAS by renal duplex sonography, including 13 unilateral RAS (3 left RAS, 10 right RAS) and 9 bilateral RAS. There were more all-cause mortality and cardiovascular death in patients with RAS than patients without RAS. By multivariate analysis, RAS was a significant predictor for all-cause death and cardiovascular death (hazard ratio [HR] = 4.155, 95% confidence interval [CI]: 1.546-11.164, P = 0.005; and HR = 3.483, 95% CI: 1.200-10.104, P = 0.022, respectively). As for composite endpoint events, including death, nonfatal myocardial infarction, ischemic stroke or intracranial hemorrhage, rehospitalization for cardiac failure, and renal replacement therapy, only angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker was significant predictor. RAS was not a significant predictor for composite endpoint events.
CONCLUSIONSOur data suggested that RAS is associated with a poorer clinical outcome in patients with heart failure.
Aged ; Atherosclerosis ; diagnosis ; etiology ; mortality ; Chi-Square Distribution ; Heart Failure ; complications ; mortality ; Humans ; Middle Aged ; Renal Artery Obstruction ; diagnosis ; etiology ; mortality ; Retrospective Studies ; Stroke Volume ; physiology
3.Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis.
Dong Geum SHIN ; Iksung CHO ; Briain O HARTAIGH ; Hee Sun MUN ; Hye Young LEE ; Eui Seock HWANG ; Jin Kyu PARK ; Jae Sun UHM ; Hui Nam PAK ; Moon Hyoung LEE ; Boyoung JOUNG
Yonsei Medical Journal 2015;56(6):1552-1558
PURPOSE: Electric cardioversion has been successfully used in terminating symptomatic atrial fibrillation (AF). Nevertheless, largescale study about the acute cardiovascular events following electrical cardioversion of AF is lacking. This study was performed to evaluate the incidence, risk factors, and clinical consequences of acute cardiovascular events following electrical cardioversion of AF. MATERIALS AND METHODS: The study enrolled 1100 AF patients (mean age 60+/-11 years) who received cardioversion at four tertiary hospitals. Hospitalizations for stroke/transient ischemic attack, major bleedings, and arrhythmic events during 30 days post electric cardioversion were assessed. RESULTS: The mean duration of anticoagulation before cardioversion was 95.8+/-51.6 days. The mean International Normalized Ratio at the time of cardioversion was 2.4+/-0.9. The antiarrhythmic drugs at the time of cardioversion were class I (45%), amiodarone (40%), beta-blocker (53%), calcium-channel blocker (21%), and other medication (11%). The success rate of terminating AF via cardioversion was 87% (n=947). Following cardioversion, 5 strokes and 5 major bleedings occurred. The history of stroke/transient ischemic attack (OR 6.23, 95% CI 1.69-22.90) and heart failure (OR 6.40, 95% CI 1.77-23.14) were among predictors of thromboembolic or bleeding events. Eight patients were hospitalized for bradyarrhythmia. These patients were more likely to have had a lower heart rate prior to the procedure (p=0.045). Consequently, 3 of these patients were implanted with a permanent pacemaker. CONCLUSION: Cardioversion appears as a safe procedure with a reasonably acceptable cardiovascular event rate. However, to prevent the cardiovascular events, several risk factors should be considered before cardioversion.
Aged
;
Amiodarone/therapeutic use
;
Anti-Arrhythmia Agents/therapeutic use
;
Atrial Fibrillation/*complications/epidemiology/*therapy
;
Bradycardia/epidemiology/etiology
;
Cardiovascular Diseases/epidemiology/*etiology
;
Electric Countershock/*methods
;
Female
;
Heart Failure/epidemiology/etiology
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Risk Factors
;
Stroke/diagnosis/epidemiology/*etiology
;
Treatment Outcome
4.Heart failure as the first manifestation of renal cell carcinoma.
Chee Meng LEE ; Allen SIM ; Gunasegaran KURUGULASIGAMONEY ; Lay Guat NG
Korean Journal of Urology 2015;56(1):82-85
We report the rare case of a patient with advanced renal cell carcinoma (RCC) who initially presented to the hospital with symptoms of cardiac failure. Preoperative cardiac studies did not reveal any underlying ischemia. After resection of a large 14-cm left renal tumor, cardiac function was noted to improve dramatically. We discuss this case of concomitant RCC and nonischemic cardiomyopathy.
Asian Continental Ancestry Group
;
Carcinoma, Renal Cell/*diagnosis/surgery
;
Cardiomyopathies/*diagnosis
;
Female
;
Heart Failure/*etiology
;
Humans
;
Middle Aged
;
Paraneoplastic Syndromes/complications
;
Thalassemia/complications
6.Acute right heart failure caused by iatrogenic brachiocephalic arteriovenous fistula following orthopedic surgery.
Kye Hun KIM ; Hyun Ju YOON ; Youngkeun AHN ; Myung Ho JEONG ; Jeong Gwan CHO ; Jong Chun PARK ; Jung Chaee KANG
The Korean Journal of Internal Medicine 2014;29(4):529-531
No abstract available.
Acute Disease
;
Adult
;
Arteriovenous Fistula/diagnosis/*etiology/surgery
;
Brachiocephalic Trunk/*injuries/radiography/surgery/ultrasonography
;
Brachiocephalic Veins/*injuries/radiography/surgery/ultrasonography
;
Dislocations/*surgery
;
Echocardiography, Doppler, Color
;
Female
;
Heart Failure/diagnosis/*etiology
;
Humans
;
*Iatrogenic Disease
;
Orthopedic Procedures/*adverse effects
;
Reoperation
;
Sternoclavicular Joint/*surgery
;
Tomography, X-Ray Computed
;
Treatment Outcome
;
Vascular System Injuries/diagnosis/*etiology/surgery
7.Amlodipine and cardiovascular outcomes in hypertensive patients: meta-analysis comparing amlodipine-based versus other antihypertensive therapy.
Seung Ah LEE ; Hong Mi CHOI ; Hye Jin PARK ; Su Kyoung KO ; Hae Young LEE
The Korean Journal of Internal Medicine 2014;29(3):315-324
BACKGROUND/AIMS: This meta-analysis compared the effects of amlodipine besylate, a charged dihydropyridine-type calcium channel blocker (CCB), with other non-CCB antihypertensive therapies regarding the cardiovascular outcome. METHODS: Data from seven long-term outcome trials comparing the cardiovascular outcomes of an amlodipine-based regimen with other active regimens were pooled and analyzed. RESULTS: The risk of myocardial infarction was significantly decreased with an amlodipine-based regimen compared with a non-CCB-based regimen (odds ratio [OR], 0.91; 95% confidence interval [CI], 0.84 to 0.99; p = 0.03). The risk of stroke was also significantly decreased (OR, 0.84; 95% CI, 0.79 to 0.90; p < 0.00001). The risk of heart failure increased slightly with marginal significance for an amlodipine-based regimen compared with a non-CCB-based regimen (OR, 1.14; 95% CI, 0.98 to 1.31; p = 0.08). However, when compared overall with beta-blockers and diuretics, amlodipine showed a comparable risk. Amlodipine-based regimens demonstrated a 10% risk reduction in overall cardiovascular events (OR, 0.90; 95% CI, 0.82 to 0.99; p = 0.02) and total mortality (OR, 0.95; 95% CI, 0.91 to 0.99; p = 0.01). CONCLUSIONS: Amlodipine reduced the risk of total cardiovascular events as well as all-cause mortality compared with non-CCB-based regimens, indicating its benefit for high-risk cardiac patients.
Amlodipine/*therapeutic use
;
Antihypertensive Agents/*therapeutic use
;
Blood Pressure/*drug effects
;
Calcium Channel Blockers/*therapeutic use
;
Chi-Square Distribution
;
Clinical Trials as Topic
;
Heart Failure/etiology/mortality/*prevention & control
;
Humans
;
Hypertension/complications/diagnosis/*drug therapy/mortality/physiopathology
;
Myocardial Infarction/etiology/mortality/*prevention & control
;
Odds Ratio
;
Risk Factors
;
Stroke/etiology/mortality/*prevention & control
;
Treatment Outcome
8.A Novel Mutation of the TAZ Gene in Barth Syndrome: Acute Exacerbation after Contrast-Dye Injection.
Gi Beom KIM ; Bo Sang KWON ; Eun Jung BAE ; Chung Il NOH ; Moon Woo SEONG ; Sung Sup PARK
Journal of Korean Medical Science 2013;28(5):784-787
A 14-month-old boy was transferred because of dilated and hypertrophied left ventricle, neutropenia, and developmental delay. After checking computed tomographic angiography with contrast-dye, the patient showed acute exacerbation and finally died from multi-organ failure despite intensive cares. From genetic analysis, we revealed that the patient had Barth syndrome and found a novel hemizygous frame shift mutation in his TAZ gene, c.227delC (p.Pro76LeufsX7), which was inherited from his mother. Herein, we report a patient with Barth syndrome who had a novel mutation in TAZ gene and experienced unexpected acute exacerbation after contrast dye injection for computed tomographic angiography.
Acidosis/etiology
;
Acute Disease
;
Adolescent
;
Barth Syndrome/diagnosis/*genetics
;
Contrast Media/adverse effects/*diagnostic use
;
Frameshift Mutation
;
Heart Failure/etiology
;
Homozygote
;
Humans
;
Male
;
Mutation
;
Pedigree
;
Sequence Analysis, DNA
;
Tomography, X-Ray Computed
;
Transcription Factors/*genetics
9.Ischemic Necrosis of the Cecum: A Single Center Experience.
Ebubekir GUNDES ; Tevfik KUCUKKARTALLAR ; Muzaffer Haldun COLAK ; Murat CAKIR ; Faruk AKSOY
The Korean Journal of Gastroenterology 2013;61(5):265-269
BACKGROUND/AIMS: Isolated cecal necrosis is a rare cause of the surgical abdomen. Its manifestation is similar to that of acute appendicitis. Thirteen cases, who were pre-diagnosed with acute abdomen and were finally diagnosed with isolated cecal necrosis after operation have been evaluated alongside with literature. METHODS: The records of 13 patients, who had isolated cecal necroses between 1995 and 2011 at Necmettin Erbakan University Meram Medical School's General Surgery Clinic (Turkey), were retrospectively evaluated. RESULTS: Eight of the patients were male, whereas 5 were female. Their mean age was 68.0+/-11.7 (range 51-84) years. All the patients had at least one accompanying disease the most frequent of which were heart failure and chronic renal failure. Ten patients had right hemicolectomy and ileotransversostomy, two had right hemicolectomy and ileostomy, and one had wedge resection to the cecum by the help of linear stapler. Mortality was seen in 5 patients (38%) in the early postoperative period. CONCLUSIONS: Isolated cecal necrosis should be considered in elderly patients with chronic diseases presenting with sudden right lower quadrant pains in the differential diagnosis. Isolated cecal necrosis may have a bad prognosis since it is seen in elderly patients with accompanying problems. Therefore, early diagnosis and immediate surgical management if necessary is important to reduce the risk of morbidity and mortality.
Age Factors
;
Aged
;
Aged, 80 and over
;
Cecum/*pathology
;
Colectomy
;
Female
;
Heart Failure/etiology
;
Humans
;
Ileostomy
;
Male
;
Middle Aged
;
Necrosis/*diagnosis/mortality/surgery
;
Renal Insufficiency, Chronic/etiology
;
Retrospective Studies
10.Pleural and pericardial empyema in a patient with continuous ambulatory peritoneal dialysis peritonitis.
Jong Hoon LEE ; Young Sun NOH ; Youn Hee LEE ; In Ae JANG ; Ho Chul SONG ; Euy Jin CHOI ; Yong Kyun KIM
The Korean Journal of Internal Medicine 2013;28(5):626-627
No abstract available.
Anti-Bacterial Agents/therapeutic use
;
Cardiac Tamponade/etiology
;
Drainage
;
Empyema, Pleural/diagnosis/*etiology/microbiology/therapy
;
Heart Diseases/diagnosis/*etiology/microbiology/therapy
;
Humans
;
Kidney Failure, Chronic/*therapy
;
Male
;
Methicillin-Resistant Staphylococcus aureus/isolation & purification
;
Middle Aged
;
Pericardial Effusion/etiology
;
Pericardial Window Techniques
;
Pericardiocentesis
;
Peritoneal Dialysis, Continuous Ambulatory/*adverse effects
;
Peritonitis/diagnosis/drug therapy/*etiology/microbiology
;
Pleural Effusion/etiology
;
Staphylococcal Infections/diagnosis/drug therapy/*etiology/microbiology
;
Tomography, X-Ray Computed
;
Treatment Outcome

Result Analysis
Print
Save
E-mail